ONCO/Reveal Multi-Cancer cfDNA Panel

The ONCO/Reveal Multi-Cancer cfDNA Panel is a robust NGS assay that interrogates 31 genes of interest across multiple solid tumor cancer types. The panel includes UIDs to increase sensitivity and is specifically designed for cell-free DNA samples (liquid biopsies). The assay uses proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®) technology for efficient single-tube target enrichment.

Benefits:

  • Streamlined single-well amplification
  • High on-target, mapping, and coverage uniformity rates
  • Targets 31 known lung cancer oncogenes
ONCO/Reveal Multi-Cancer cfDNA Panel Target Genes (31 in total)
AKT1 BRAF ERBB3 GNAS KIT NRAS PIK3CA SF3B1
ALK CTNNB1 ESR1 HRAS KRAS NTRK1 PPP2R1A SMAD4
APC EGFR FBXW7 IDH1 MAP2K1 NTRK3 PTEN TP53
ARAF ERBB2 FGFR2 IDH2 MET PDGFRA ROS1